A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma-Reference-Cited by-同舟云学术

A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma

Published:2021-06-09 Issue:26 Volume:40 Page:4413-4424
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wu Jie,Li Lan,Zhang Huibo,Zhao Yaqi,Zhang Haohan,Wu Siyi,Xu Bin^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-021-01853-y.pdf

Reference49 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Bender E. Epidemiology: the dominant malignancy. Nature. 2014;513:S2–3.

3. Jamal-Hanjani M, Quezada SA, Larkin J, Swanton C. Translational implications of tumor heterogeneity. Clin Cancer Res. 2015;21:1258–66.

4. Carter BW, Godoy MC, Wu CC, Erasmus JJ, Truong MT. Current controversies in lung cancer staging. J Thorac Imaging. 2016;31:201–14.

5. Martinez-Terroba E, Behrens C, de Miguel FJ, Agorreta J, Monso E, Millares L, et al. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients. J Pathol. 2018;245:421–32.

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of a 3-gene ferroptosis-related signature in lung cancer via LASSO analysis and cellular functions of UBE2Z;Computational Biology and Chemistry;2024-12

2. Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML);Frontiers in Genetics;2024-08-14

3. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer;Frontiers in Immunology;2024-08-13

4. Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients;Current Medical Science;2024-08

5. Clinical Significance, Immune Landscape and Immunotherapy Efficacy Analyses of Cuproptosis-Tumor Immunological Phenotype-Related Gene Score Based Prognostic Model in Breast Cancer;2024-07-19